SCHEMBL17436330

SCHEMBL17436330

COc1ccc(-c2cnc(Cl)nc2)c(F)c1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK1 P49759 1/20 0.47
AMY1A P0DUB6 3/20 0.46
CYP17A1 P05093 3/20 0.44
CYP11B1 P15538 3/20 0.44
CYP11B2 P19099 3/20 0.44
ERN1 O75460 1/20 0.44
ALOX5AP P20292 2/20 0.43
FEN1 P39748 2/20 0.43
CTSA P10619 2/20 0.43
PTGS1 P23219 1/20 0.43
PTGS2 P35354 1/20 0.43
USP7 Q93009 1/20 0.43
NPC1 O15118 1/20 0.41
RAB9A P51151 1/20 0.41
CHRNA7 P36544 1/20 0.40
NPSR1 Q6W5P4 1/20 0.40
PRKAB2 O43741 1/20 0.40
PRKAG1 P54619 1/20 0.40
PRKAA2 P54646 1/20 0.40
PRKAA1 Q13131 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17436180 0.87 KDM1A (0.45) AMY1ACYP17A1CYP11B1CYP11B2NPC1
SCHEMBL17436348 0.79 FEN1 (0.46) CLK1ALOX5APFEN1
SCHEMBL29904245 0.77 AMY1A (0.46) CLK1AMY1ACYP17A1CYP11B1CYP11B2
SCHEMBL27415952 0.77 AMY1A (0.46) CLK1AMY1ACYP17A1CYP11B1CYP11B2
SCHEMBL27781767 0.77 CYP2C19 (0.58) AMY1AERN1USP7PRKAB2PRKAG1
SCHEMBL8612536 0.77 MAPT (0.46) FEN1NPSR1
SCHEMBL10340365 0.76 AMY1A (0.50) AMY1AERN1RAB9ANPSR1PRKAB2
SCHEMBL12987241 0.75 AMY1A (0.50) AMY1ACYP17A1CYP11B1CYP11B2CTSA
SCHEMBL31511341 0.75 PIN1 (0.52) RAB9A
SCHEMBL12396451 0.74 ERN1 (0.52) CLK1AMY1ACYP17A1CYP11B1CYP11B2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107074812-B Substituted pyrimidine compounds 格吕伦塔尔有限公司 2020-08-21 CN disclosed
EP-3527561-A1 NOVEL SUBSTITUTED PYRIMIDINE COMPOUNDS Grünenthal GmbH (DE) 2019-08-21 EP disclosed
US-10189854-B2 Substituted pyrimidine compounds GRUENENTHAL GMBH (DE) 2019-01-29 US disclosed
EP-3169681-A1 NOVEL SUBSTITUTED PYRIMIDINE COMPOUNDS Grünenthal GmbH (DE) 2017-05-24 EP disclosed
US-20170066776-A1 Novel substituted pyrimidine compounds GRUENENTHAL GMBH (DE) 2017-03-09 US disclosed
US-9540349-B2 Substituted pyrimidine compounds GRUENENTHAL GMBH (DE) 2017-01-10 US disclosed
US-20160016937-A1 Novel substituted pyrimidine compounds GRUENENTHAL GMBH (DE) 2016-01-21 US disclosed
WO-2016008593-A1 NOVEL SUBSTITUTED PYRIMIDINE COMPOUNDS Grünenthal GmbH (DE) 2016-01-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10189854-B2 Substituted pyrimidine compounds TYMP, PDE4A, DPYD CLK1 4504/4885AMY1A 2342/4885CYP17A1 985/4885
US-20160016937-A1 Novel substituted pyrimidine compounds PDE4A, PDE4B, TYMP CLK1 4481/4885AMY1A 2334/4885CYP17A1 798/4885
US-20170066776-A1 Novel substituted pyrimidine compounds PDE4A, PDE4B, TYMP CLK1 4481/4885AMY1A 2334/4885CYP17A1 798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.